Eleusis was founded by Shlomi Raz in 2017.

Who are Eleusis's investors?

Eleusis's investors include Noetic.

How much funding has Eleusis raised?

Eleusis has disclosed $465K raised across 1 round.

Eleusis is headquartered in New York, US.

New York, US · Founded 2017 · 1 known investors

Your email: who you already know at Eleusis, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Eleusis team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Focused on serotonin 2A receptor agonists (psychedelics) by managing psychoactivity. (Exited)

Eleusis was founded in 2017 by Shlomi Raz.

Shlomi RazFounder

Robert M. HershbergNamed on SEC filing

David SocksNamed on SEC filing

Joanna Grace NatasegaraNamed on SEC filing

Mary Frances VernonNamed on SEC filing

John Bryan CliftonNamed on SEC filing

John TuckerNamed on SEC filing

Patrick John Stephen VernonNamed on SEC filing

Esther van den BoomNamed on SEC filing

Form D private placements

$465K disclosed across 1 round · 2022

▶$465KraisedMar 2022 · 9 investors · Biotechnology

Rule 506(c)

Officers, directors & promoters on the filing

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

What does Eleusis do?: Focused on serotonin 2A receptor agonists (psychedelics) by managing psychoactivity. (Exited)
Who founded Eleusis?: Eleusis was founded by Shlomi Raz in 2017.
Who are Eleusis's investors?: Eleusis's investors include Noetic.
How much funding has Eleusis raised?: Eleusis has disclosed $465K raised across 1 round.
Where is Eleusis headquartered?: Eleusis is headquartered in New York, US.